Trial intelligence / Profile preview

Intraoperative cefoxitin levels during pediatric cardiac surgery with cardiopulmonary bypass

2016-004800-71Phase 2Completed

Sponsor
Ospedale Pediatrico Bambino Gesù
Start
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of cefoxitin in Cardiovascular Malformation (CVM) (4 arms), sponsored by Ospedale Pediatrico Bambino Gesù. Primary endpoint: Intraoperative cefoxitin blood levels. Started Dec 2016; status: completed.

02

Drugs

cefoxitin
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on 2016-004800-71.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-004800-71.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call